Skip to Main Content

Haemonetics Corporation

HAE Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
HAE Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
HAE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
HAE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in HAE holdings by institutional investors

Quarterly net insider trading by HAE's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $40,000 Jan 27, 2014 Issue: Health Issues
  • $40,000 Oct 16, 2013 Issue: Health Issues
  • $40,000 Jul 24, 2013 Issue: Health Issues
  • $40,000 Apr 08, 2013 Issue: Health Issues
  • $40,000 Jan 22, 2013 Issue: Health Issues
  • $20,000 Jan 14, 2013 Issue: Health Issues
  • $60,000 Dec 27, 2012 Issue: Health Issues

HAE Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

HAE Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
HAE Income Statement
HAE Balance Sheet
HAE Cash Flow
U.S. Patents

New HAE patent grants

  • Patent Title: System and method for enhancing plasma acquisition at a plasma donation center Oct. 07, 2025
  • Patent Title: Plasmapheresis centrifuge bowl Sep. 09, 2025
  • Patent Title: System and method for collecting plasma Aug. 05, 2025
  • Patent Title: System and method for collecting plasma Jun. 10, 2025
  • Patent Title: System and method for collecting plasma Jan. 07, 2025
  • Patent Title: System and method for collecting plasma Dec. 24, 2024
  • Patent Title: Bracket, thrombelastography device, and support system Dec. 17, 2024
  • Patent Title: Continuous flow separation chamber Jul. 23, 2024
  • Patent Title: Container for blood component cooling and freezing Apr. 23, 2024
  • Patent Title: Thrombelastography device, heating apparatus, blood coagulation analysis system and rotational angle measurement method Mar. 12, 2024
  • Patent Title: Hemostasis measurement device quality control formulations Feb. 20, 2024
  • Patent Title: Rfid tag and method of securing same to object Mar. 27, 2018
  • Patent Title: System and method for automated platelet wash Dec. 05, 2017
  • Patent Title: System and method for the re-anticoagulation of platelet rich plasma Oct. 17, 2017
  • Patent Title: Apheresis bowl with improved vibration characteristics Jun. 20, 2017
  • Patent Title: Frangible rfid tag and method of producing same Apr. 18, 2017
  • Patent Title: Donated blood collection kit Jan. 10, 2017
  • Patent Title: System and method for automated separation of whole blood Jun. 21, 2016
  • Patent Title: System and method for optimized apheresis draw and return Jun. 14, 2016
  • Patent Title: Methodologies and reagents for detecting fibrinolysis and hyperfibrinolysis in a blood sample using viscoelastic analysis May. 31, 2016
  • Patent Title: Blood processing device Apr. 26, 2016
  • Patent Title: System and method for collecting platelets and anticipating plasma return Apr. 05, 2016
  • Patent Title: Blood-donation system Apr. 05, 2016
  • Patent Title: System and method for the re-anticoagulation of platelet rich plasma Feb. 02, 2016
  • Patent Title: Three-line apheresis system and method Aug. 04, 2015
  • Patent Title: Adaptable perioperative cell-salvage system and methods and disposable units for same Mar. 24, 2015
  • Patent Title: Blood plasma storage bottle with locking cap Feb. 24, 2015
  • Patent Title: Automatic blood collection system Dec. 30, 2014
  • Patent Title: Non-reopening tubing clamp and method of use thereof Dec. 09, 2014
  • Patent Title: System and method for the re-anticoagulation of platelet rich plasma Sep. 16, 2014
  • Patent Title: System and method for automated platelet wash Aug. 19, 2014
  • Patent Title: System and method for plasma reduced platelet collection Aug. 19, 2014
  • Patent Title: Apparatus and method for administration of mother's milk Jul. 08, 2014
  • Patent Title: Tear seal moveable ground jaw for a tubing sealer Jul. 08, 2014
  • Patent Title: System and method for active cooling of stored blood products Jun. 24, 2014
  • Patent Title: System and method for optimized apheresis draw and return Apr. 22, 2014
  • Patent Title: System and method for optimized apheresis draw and return Feb. 11, 2014
  • Patent Title: Multi-purpose tubing apparatus Feb. 04, 2014
  • Patent Title: Method for pre-filtering blood in a blood collection and processing system Jan. 14, 2014
  • Patent Title: Three-line apheresis system and method Jan. 14, 2014
  • Patent Title: Pressure monitoring within a fluid cassette Nov. 26, 2013
  • Patent Title: System and method for plasma reduced platelet collection Jun. 04, 2013
  • Patent Title: Monitor for charging series connected batteries Apr. 23, 2013
  • Patent Title: Adaptable perioperative cell-salvage system and methods and disposable units for same Apr. 02, 2013
  • Patent Title: Apparatus and methods for monitoring transfusion of blood Sep. 11, 2012
  • Patent Title: Wound drainage suction relief Apr. 17, 2012
  • Patent Title: Postoperative fluid monitoring and alert system Apr. 17, 2012
  • Patent Title: Reservoir for use with a blood collection system Apr. 17, 2012
  • Patent Title: Blood processing device Feb. 15, 2011
  • Patent Title: Support pole for holding solutions Feb. 02, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to HAE from public contracts

HAE News

Recent insights relating to HAE

CNBC Recommendations

Recent picks made for HAE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HAE

HAE Analyst Ratings

HAE Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
HAE Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $HAE stock a Buy, Sell, or Hold?

  • What is the price target for $HAE stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

HAE Top Shareholders
Shareholder
Shares Held
HAE Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $HAE stock?

  • Who owns the most shares of $HAE stock?

  • What funds own $HAE stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

HAE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view HAE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About HAE

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

  • Address Boston, MA
  • Market Cap 3.7 billion
  • Employees 3,023
  • Industrial Classification Surgical & Medical Instruments & Apparatus
Back To Top